JP2023539694A5 - - Google Patents

Info

Publication number
JP2023539694A5
JP2023539694A5 JP2023537723A JP2023537723A JP2023539694A5 JP 2023539694 A5 JP2023539694 A5 JP 2023539694A5 JP 2023537723 A JP2023537723 A JP 2023537723A JP 2023537723 A JP2023537723 A JP 2023537723A JP 2023539694 A5 JP2023539694 A5 JP 2023539694A5
Authority
JP
Japan
Prior art keywords
acrylamide
methyl
alkyl
compound according
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023537723A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539694A (ja
JP7784430B2 (ja
Filing date
Publication date
Priority claimed from GBGB2013728.7A external-priority patent/GB202013728D0/en
Application filed filed Critical
Publication of JP2023539694A publication Critical patent/JP2023539694A/ja
Publication of JP2023539694A5 publication Critical patent/JP2023539694A5/ja
Application granted granted Critical
Publication of JP7784430B2 publication Critical patent/JP7784430B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023537723A 2020-09-01 2021-09-01 新規化合物 Active JP7784430B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2013728.7 2020-09-01
GBGB2013728.7A GB202013728D0 (en) 2020-09-01 2020-09-01 Novel compounds
PCT/GB2021/052261 WO2022049376A1 (en) 2020-09-01 2021-09-01 Novel compounds

Publications (3)

Publication Number Publication Date
JP2023539694A JP2023539694A (ja) 2023-09-15
JP2023539694A5 true JP2023539694A5 (cg-RX-API-DMAC10.html) 2024-09-09
JP7784430B2 JP7784430B2 (ja) 2025-12-11

Family

ID=72749708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537723A Active JP7784430B2 (ja) 2020-09-01 2021-09-01 新規化合物

Country Status (12)

Country Link
US (1) US12630516B2 (cg-RX-API-DMAC10.html)
EP (1) EP4208442B1 (cg-RX-API-DMAC10.html)
JP (1) JP7784430B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230069915A (cg-RX-API-DMAC10.html)
CN (1) CN116096705A (cg-RX-API-DMAC10.html)
AU (1) AU2021337195A1 (cg-RX-API-DMAC10.html)
CA (1) CA3190645A1 (cg-RX-API-DMAC10.html)
ES (1) ES3055772T3 (cg-RX-API-DMAC10.html)
GB (1) GB202013728D0 (cg-RX-API-DMAC10.html)
IL (1) IL300900A (cg-RX-API-DMAC10.html)
MX (1) MX2023002525A (cg-RX-API-DMAC10.html)
WO (1) WO2022049376A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202013731D0 (en) 2020-09-01 2020-10-14 Nrg Therapeutics Ltd Novel cmpounds
WO2023209651A1 (en) * 2022-04-29 2023-11-02 Dong-A St Co., Ltd. Bicycle compounds as tead inhibitor
GB202300833D0 (en) 2023-01-19 2023-03-08 Nrg Therapeutics Ltd Novel compounds
CN119306612B (zh) * 2023-07-14 2026-03-20 中国科学院大连化学物理研究所 一种反式氨基茚满的制备方法
CN121866248A (zh) 2023-09-05 2026-04-14 Nrg治疗有限公司 作为mptp抑制剂起作用的吡啶衍生物
GB202410534D0 (en) 2024-07-18 2024-09-04 Nrg Therapeutics Ltd Novel method and uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2852659B2 (ja) * 1988-03-03 1999-02-03 富山化学工業株式会社 ピペラジン誘導体およびその塩
JPWO2003020313A1 (ja) 2001-09-04 2004-12-16 小野薬品工業株式会社 スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤
AU2002354476A1 (en) 2001-12-14 2003-06-30 Japan Tobacco Inc. Pyrazolopyridine derivatives and medicinal use thereof
JP2006512306A (ja) * 2002-08-29 2006-04-13 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途
JP2006160916A (ja) * 2004-12-08 2006-06-22 Fuji Photo Film Co Ltd インクジェット用インク組成物及びインクジェット記録方法
JP5495206B2 (ja) 2006-10-24 2014-05-21 コンジエニア・ソシエタ・ア・レスポンサビリタ・リミタータ 変性性組織障害をmptの阻害により防止するための薬剤としてのフェニル置換マレイミド
EP2179984A1 (en) 2008-10-27 2010-04-28 Congenia S.r.l. Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
WO2011087051A1 (ja) 2010-01-14 2011-07-21 国立大学法人金沢大学 S1p2受容体アンタゴニストを含む粥状動脈硬化治療薬
JP5990106B2 (ja) 2011-01-28 2016-09-07 佐藤製薬株式会社 縮環化合物
JP2017538676A (ja) 2014-11-05 2017-12-28 ザ ユニバーシティ オブ カンザス ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤
WO2016090371A2 (en) 2014-12-05 2016-06-09 An2H Discovery Limited Parkin ligase activation methods and compositions
CA2884607A1 (en) 2015-03-11 2016-09-11 Stealth Peptides International, Inc. Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions
WO2019002624A1 (de) 2017-06-30 2019-01-03 Kleuser, Burkhard Mittel zur therapie entzündlicher darmerkrankungen
GB202013731D0 (en) 2020-09-01 2020-10-14 Nrg Therapeutics Ltd Novel cmpounds

Similar Documents

Publication Publication Date Title
KR100704215B1 (ko) 8-아자프로스타글란딘 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
AU2015361018B2 (en) 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
JP2024086819A (ja) 化合物、組成物、及び、方法
JP2023539695A5 (cg-RX-API-DMAC10.html)
JP2025508898A5 (cg-RX-API-DMAC10.html)
JP2024166311A (ja) 化合物、組成物、及び、方法
AR059895A1 (es) Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos
NZ601967A (en) Pde10 inhibitors and related compositions and methods
JP2018531981A5 (cg-RX-API-DMAC10.html)
CN1610557A (zh) 6-氟双环[3.1.0]己烷衍生物
CN102471296A (zh) Bace抑制剂
PE20091444A1 (es) Derivados de isoxazolo-pirazina
JP2022540434A5 (cg-RX-API-DMAC10.html)
JP2023503331A5 (cg-RX-API-DMAC10.html)
HUE034820T2 (en) Sulphamoyl arylamides and their use as medicaments for the treatment of hepatitis B
BRPI1014050A2 (pt) composto, composição farmacêutica, e, uso de um composto
PL209339B1 (pl) Pochodne dioksano-2- alkilokarbaminianów, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie
JP2023503601A5 (cg-RX-API-DMAC10.html)
JP6454335B2 (ja) カテプシンシステインプロテアーゼ阻害剤
WO2023107648A3 (en) Synthesis of ester, carbonate, and carbamate-derived novel biodegradable ionizable lipids from methyl ricinoleate or methyl 12-hydroxystearate and its applications
JP2023535926A5 (cg-RX-API-DMAC10.html)
JP2023123607A (ja) ベンゼン誘導体
BR112021007784A2 (pt) processo para preparar compostos de isoxazolina opticamente enriquecidos
WO2018102399A1 (en) Methods of dose administration for treating or preventing cognitive impairment using indane acetic acid derivatives
HRP20170485T1 (hr) Derivati 1-[1-(benzoil)pirolidin-2-karbonil]pirolidin-2-karbonitrila